(Total Views: 490)
Posted On: 10/01/2020 9:52:42 AM
Post# of 594
Business Wire•October 1, 2020
United Health Products, Inc. (OTCPK: UEEC, "UHP"
today announced that it has submitted documents requested by the FDA in conjunction with its PMA (Class III) application to use HemoStyp in internal surgeries. The company expects the FDA to grant approval to its PMA (Class III) application or request additional information within 30 days.
All details and updates regarding the Human Trials are now available to the public at:
https://www.clinicaltrials.gov/ct2/show/NCT03...amp;rank=1
United Health Products, Inc. (OTCPK: UEEC, "UHP"
today announced that it has submitted documents requested by the FDA in conjunction with its PMA (Class III) application to use HemoStyp in internal surgeries. The company expects the FDA to grant approval to its PMA (Class III) application or request additional information within 30 days. All details and updates regarding the Human Trials are now available to the public at:
https://www.clinicaltrials.gov/ct2/show/NCT03...amp;rank=1
(0)
(0)
